Warning:
"Antibiotic resistance — but broadly we are talking about antimicrobial resistance, or AMR — is widespread and threatening the future of modern medicine" — Jean-Pierre Nyemazi acting director WHO AMR dept at 6th Annual Global Media Forum on AMR virtual conference Monday.
Senior officials said progress in prevention, diagnosis, appropriate use too slow to meet global targets set at UN General Assembly 2024 for 2030.
"Procedures we now take for granted become far riskier when antibiotics and antimicrobials no longer work" — Nyemazi.
Numbers:
- In 2021 alone directly responsible for more than 1M deaths and linked to about 4.7M others per WHO.
- Latest global surveillance: 2023 one in every six laboratory-confirmed bacterial infections flagged to WHO resistant to antibiotics used to treat it — says Sylvia Bertagnolo head surveillance AMR.
- Projection: drug-resistant infections could contribute to more than 39 million deaths worldwide over next 25 years if current trends persist — Lancet Global Burden study earlier — Nature 2025 charts noted same 39M figure but WHO repeated.
National action plans gap:
Annual survey conducted by WHO, UN Environment Programme, World Organization for Animal Health, FAO — 183 countries 2026:
- 173 reported having national action plan vs 79 in 2017 — nearly 9 in 10 — but only 42 said plans financed and implemented.
- Translation commitments into funded programs failing — off pace 2030 targets.
- Pravasha Prakash AMR technical officer — progress but needs speeding.
Infection prevention — most effective to reduce need antibiotics — critical gap:
- 128 countries now have national infection prevention and control programs and guidelines vs 90 in 2018.
- But only 69 countries 38% implemented nationwide — far short target 90% by 2030 — survey flagged.
- Routine surgery, childbirth, cancer chemotherapy could become life-threatening without effective antibiotics.
What WHO released:
Two new tools to strengthen diagnostic capabilities — Landscape Analysis of Commercially Available and Pipeline In Vitro Diagnostics for Bacterial Priority Pathogens — and guidance on antibacterial agents pipeline. WHO notes global antibiotic pipeline facing dual crisis: scarcity of drugs in development and lack innovation — 2025 reports.
Misuse and overuse driving: over-the-counter sales without prescription, agriculture use growth promotion, inadequate water sanitation hygiene.
For India, Pakistan, Bangladesh high burden — self-medication common.
WHO calls for: strengthen stewardship, funded national plans, infection prevention, diagnostics, surveillance, R&D incentives.
#AMR #WHO #AntibioticResistance #39Million #OneInSix #InfectionControl #NationalActionPlan #2030Targets #GlobalHealth #Antibiotics